1 day REPL Stock Rises on FDA’s Priority Review for Melanoma Drug BLA Zacks

   X     

6 days Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts Zacks

   X     

1 week Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO YouTube

   X     

1 week Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha

   X     

2 weeks Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

   X     

2 weeks Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell? Zacks

   X     

3 weeks Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors Zacks

   X     

3 weeks 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

   X     

3 weeks Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now? Zacks

   X     

3 weeks Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo ‘Subcu’ Approval Seeking Alpha

   X     

4 weeks Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know Zacks

   X     

4 weeks Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now? Zacks

   X     

1 month BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer Zacks

   X     

1 month Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha

   X     

1 month Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued Seeking Alpha

   X     

1 month Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today Zacks

   X     

1 month Bristol Myers Squibb Stock Earns 83 RS Rating Investor's Business Daily

   X     

1 month Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

1 month Bristol-Myers: Still An Opportunity Yielding Over 4% Seeking Alpha

   X     

1 month Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy Investing.com

   X     

1 month BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

   X     

1 month Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know Zacks

   X     

1 month Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

   X     

1 month Bristol Myers (BMY) Upgraded to Buy: Here’s Why Zacks

   X     

1 month Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now? Zacks

   X     

2 months Analyst Report: Bristol-Myers Squibb Co. Yahoo Finance

   X     

2 months Bristol-Myers Squibb Company (BMY) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 months Is Bristol-Myers Squibb Stock a Millionaire Maker? Yahoo Finance

   X     

2 months Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney YouTube

   X     

2 months Prime Medicine’s Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies Seeking Alpha

   X     

2 months 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Seeking Alpha

   X     

2 months AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

   X     

2 months Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug Zacks

   X     

2 months Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 months Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Bristol-Myers Squibb: Buy This Bargain Before It’s Gone Seeking Alpha

   X     

2 months Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript) Seeking Alpha

   X     

2 months Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell? Zacks

   X     

2 months Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

   X     

3 months Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade Investor's Business Daily

   X     

3 months Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View Zacks

   X     

3 months Bristol Myers Screams To A Year-High After Walloping Profit Expectations Investor's Business Daily

   X     

3 months Pallas Capital Advisors LLC Purchases 9,537 Shares of Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Wealth Enhancement Advisory Services LLC Cuts Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? Zacks

   X     

3 months Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren Seeking Alpha

   X     

3 months Allspring Global Investments Holdings LLC Has $11.12 Million Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Bristol Myers Squibb’s Q3 Earnings Are Likely To Be Strong Seeking Alpha

   X     

3 months Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know Zacks

   X     

3 months Impact Partnership Wealth LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Leerink Partnrs Issues Pessimistic Forecast for BMY Earnings MarketBeat

   X     

3 months FY2028 Earnings Estimate for BMY Issued By Leerink Partnrs MarketBeat

   X     

3 months Sequoia Financial Advisors LLC Has $7.40 Million Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Bristol Myers (BMY) Upgraded to Buy: Here’s What You Should Know Zacks

   X     

3 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks

   X     

3 months Raleigh Capital Management Inc. Has $2.20 Million Holdings in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X     

3 months Commonwealth Equity Services LLC Decreases Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

   X